Pfênex, Inc.
(NYSE Amex Equities : PFNX)

( )
PFNX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
0.12%282.621.4%$843.46m
CELGCelgene Corp.
-0.64%109.321.3%$567.22m
AMGNAmgen, Inc.
-0.09%220.671.3%$527.41m
GILDGilead Sciences, Inc.
-1.20%64.291.0%$392.22m
ILMNIllumina, Inc.
0.22%306.673.5%$324.05m
VRTXVertex Pharmaceuticals, Inc.
0.10%210.001.9%$322.62m
REGNRegeneron Pharmaceuticals, Inc.
-1.36%340.192.6%$270.57m
EXASEXACT Sciences Corp.
0.13%82.1624.0%$218.38m
ALXNAlexion Pharmaceuticals, Inc.
-0.37%107.972.0%$179.41m
SGENSeattle Genetics, Inc.
0.85%115.736.1%$140.87m
BMRNBioMarin Pharmaceutical, Inc.
0.17%75.174.3%$126.88m
SRPTSarepta Therapeutics, Inc.
0.45%97.9014.6%$118.56m
AAgilent Technologies, Inc.
-0.38%77.961.6%$98.09m
BGNEBeiGene Ltd.
-1.13%196.012.1%$90.37m
NBIXNeurocrine Biosciences, Inc.
1.41%114.645.0%$88.13m

Company Profile

Pfênex, Inc. is a clinical-stage biotechnology company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes biosimilars and vaccines. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.